Medite Cancer Diagnostics, Inc.
Headquarters Chicago, IL
Financials
FORMNAMEDATE FILED
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4054/1/201910-QQ311/14/201810-QQ28/10/201810-QQ16/22/201810-KFY 20175/17/2018NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB5/14/2018NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4053/29/2018
Prospectuses and Registrations
FORMNAMEDATE FILED
15-12G/ASecurities registration termination4/2/201915-12GSecurities registration termination3/22/2019S-3Registration statement under Securities Act of 19338/13/2008424B3Prospectus10/7/2002S-2/ARegistration of securities10/4/2002S-2Registration of securities9/27/2002S-8Securities to be offered to employees in employee benefit plans8/9/2002
Proxies
FORMNAMEDATE FILED
PRE 14COther preliminary information statements2/28/2019PRE 14COther preliminary information statements8/27/2018PRE 14COther preliminary information statements8/1/2017PRE 14COther preliminary information statements3/10/2017PRER14CInformation statements11/22/2016PRE 14COther preliminary information statements11/16/2016DEFR14CRevised information statement materials, definitive1/8/2016
News
FORMNAMEDATE FILED
8-KFinancial Statements and Exhibits5/6/20198-KNews Release4/23/20198-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers3/18/20198-KBankruptcy or Receivership1/3/20198-KEntry into a Material Definitive Agreement12/6/20188-K/AFinancial Statements and Exhibits11/7/20188-KFinancial Statements and Exhibits10/31/2018
Ownership
Others
FORMNAMEDATE FILED
DNotice of Exempt Offering of Securities10/26/2018DEF 14COther definitive information statements9/6/2018DNotice of Exempt Offering of Securities7/12/2018DNotice of Exempt Offering of Securities2/22/2018DNotice of Exempt Offering of Securities10/16/2017DEF 14COther definitive information statements8/11/2017DEF 14COther definitive information statements3/21/2017